Literature DB >> 9658190

A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells.

K Tang1, H Wu, S K Mahata, D T O'Connor.   

Abstract

The mitogen-activated protein kinase (MAPK) pathway plays a pivotal role in intracellular signaling, and this cascade may impinge on cAMP response elements (CREs) of target genes. Both the MAPK pathway and chromogranin A expression may be activated by cytosolic calcium influx, and calcium-dependent signals map onto the chromogranin A promoter proximal CRE. We therefore probed the role of the MAPK pathway in chromogranin A biosynthesis after secretory stimulation of PC12 pheochromocytoma cells by the nicotinic cholinergic pathway, the physiological secretory trigger. Chemical inhibition of either MAPK or MAPK kinase blocked the response of a transfected chromogranin A promoter to nicotine or protein kinase C activation [by phorbol-12-myristate-13-acetate (PMA)], although nicotine-evoked catecholamine secretion was unaffected. Activation of the MAP kinase cascade (Ras, Raf, MAPK, or CREB kinase) by cotransfection of pathway components stimulated the chromogranin A promoter. Cotransfection of MAPK pathway dominant negative mutants (for Raf, MAPK, or CREB kinase) blocked nicotinic or PMA activation of chromogranin A, although a dominant negative Ras mutant was without effect. MAPK pathway enzymatic activity was stimulated by both nicotine and PMA. Point mutations of the chromogranin A CRE suggested that this element was necessary in cis for stimulation by nicotine, PMA, or chemical activation of the MAPK pathway. Transfer of the CRE to a heterologous promoter conferred inducibility by not only nicotine or cAMP but also MAPK activation. Expression of the CREB antagonist KCREB blocked the response of the chromogranin A promoter to nicotine, cAMP, or MAPK pathway activation by either chemical stimulation or cotransfection of active cascade components. Chromogranin A mRNA responded to MAPK pathway manipulation in a fashion similar to the transfected chromogranin A promoter, in both direction and magnitude. We conclude that the MAPK pathway is a necessary intermediate in signaling from the nicotinic receptor to secretory protein transcription, although not to catecholamine secretion. In trans, this response seems to involve the following signal cascade: protein kinase C --> Raf --> MAPK kinase --> MAPK --> CREB kinase --> CREB. In cis, activation by the cascade maps onto the chromogranin A promoter proximal CRE, which is both necessary and sufficient to confer the response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658190     DOI: 10.1124/mol.54.1.59

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

1.  Region-specific transcriptional response to chronic nicotine in rat brain.

Authors:  J K Kane; T Barrett; M P Vawter; R Chang; J Z Ma; D M Donovan; B Sharp; K G Becker; M D Li
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

2.  Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function.

Authors:  P Chowdhury; C Bose; K B Udupa
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

3.  Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action.

Authors:  Dongcheng Lu; Henglin Yan; Timothy Othman; Christopher P Turner; Thomas Woolf; Scott A Rivkees
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

4.  [The role of extracellular signal regulated kinase 1/2 in mediating osteodifferentiation of human periodontal ligament cells induced by cyclic stretch].

Authors:  Song Jing; Ren Dapeng; Yan Shiguo; Lan Jing; Yuan Xiao; Guo Qingyuan; Qi Xiangmin
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-10-01

5.  Glucose attenuates impairments in memory and CREB activation produced by an α4β2 but not an α7 nicotinic receptor antagonist.

Authors:  Ken A Morris; Sisi Li; Duat D Bui; Paul E Gold
Journal:  Neuropharmacology       Date:  2012-11-16       Impact factor: 5.250

6.  beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice.

Authors:  Jennifer A Davis; Thomas J Gould
Journal:  Psychopharmacology (Berl)       Date:  2006-11-30       Impact factor: 4.530

7.  Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer.

Authors:  Jingmei Zhang; Opal Kamdar; Wei Le; Glenn D Rosen; Daya Upadhyay
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-01       Impact factor: 6.914

8.  Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.

Authors:  Y Chen; F Rao; J L Rodriguez-Flores; N R Mahapatra; M Mahata; G Wen; R M Salem; P-A B Shih; M Das; N J Schork; M G Ziegler; B A Hamilton; S K Mahata; D T O'Connor
Journal:  Kidney Int       Date:  2008-04-23       Impact factor: 10.612

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach.

Authors:  Xinhua Liu; Meng Liu; Xia Li; Lihua Zhang; Rui Fan; Ju Wang
Journal:  Mol Neurobiol       Date:  2014-09-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.